/* Via Victoria: hard lock to the intended light colour palette on mobile browsers. */
A short illustrated guide from our family experience. Swipe sideways on your phone to see all six slides.
Blinatumomab is a bispecific antibody therapy that helps bring T cells close to CD19-positive B cells. It is used in selected forms of B-cell acute lymphoblastic leukaemia under specialist care.
The six illustrated slides below retain their original Slovak text. This English overview is informational and is not a substitute for medical advice. Individual diagnosis and treatment decisions must be made by a qualified medical team.